Dabigatran, electrical cardioversion and measuring the aPTT. A safety measure or an unnecessary assessment?

    loading  Checking for direct PDF access through Ovid

Abstract

We present two case reports of patients treated with dabigatran for stroke prevention. Both have non-valvular atrial fibrillation and both were scheduled for direct current electrical cardioversion (DCCV). Both had their activated partial thromboplastin time (aPTT) measured prior to their DCCV to assess the anticoagulant activity of dabigatran. The decision to measure the aPTT resulted in differing levels to otherwise straightforward cases.

Related Topics

    loading  Loading Related Articles